COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
NuvOx Therapeutics is a clinical-stage biotech developing DDFPe (dodecafluoropentane emulsion) intravenous oxygen-delivery platform to improve tissue oxygenation for hypoxia-driven indications, with Phase IIb GBM, stroke, and sickle cell programs.
